Federica Fogacci Presents The New ILEP Consensus Paper
Federica Fogacci, Young Fellow at European Atherosclerosis Society, shared on LinkedIn:
”Rethinking lipid management for stroke prevention – new ILEP Consensus Paper
Ischemic stroke accounts for ~66% of all strokes and is now the third leading cause of death worldwide – yet a large proportion of patients still have undiagnosed or undertreated lipid disorders, both before and after a cerebrovascular event.
Together with an amazing international team from the International Lipid Expert Panel (ILEP), in collaboration with the ESC Council on Stroke, we have just published a new consensus paper on lipid management for primary and secondary stroke prevention in Progress in Cardiovascular Diseases
What’s inside the paper?
- Why dyslipidaemia (including LDL-C and Lp(a)) is a causal driver of ischaemic stroke
- Clear, pragmatic LDL-C and apoB targets for patients at risk of stroke and for those with prior stroke/TIA
- A strong message in favour of early, intensive and often combination lipid-lowering therapy (statins + ezetimibe ± PCSK9 inhibitors, bempedoic acid, inclisiran) to close the huge treatment gap in real-world practice
- How to think about Lp(a), triglyceride-rich lipoproteins, and non-HDL-C in stroke prevention
- The ILEP-SMILE framework: simple lifestyle “tips for the healthy cerebrum” to integrate pharmacological and non-pharmacological prevention
Our message is simple – and fully implementable in everyday practice:
“Lower is better, earlier is better, and longer is better” for LDL-C and overall lipid management in patients at risk of stroke and after stroke.
Even partial, consistent implementation of these principles could translate into fewer strokes and better long-term outcomes for our patients.”
Read the full article here.
Article: Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP)
Authors: Maciej Banach, Peter P. Toth, Hyo-Jeong Ahn, Agata Bielecka-Dabrowa, Arrigo F.G. Cicero, Adrian Covic, Mayank Dalakoti, Carlos Escobar, Federica Fogacci, Dan Gaita, Laura Gaita, Jacek Jóźwiak, Gustavs Latkovskis, Joanna Lewek, George Ntaios, Boguslaw Okopień, Ivan Pećin, Daniel Pella, Peter E. Penson, Marco Proietti, Gregory Y.H. Lip
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 5, 2026, 19:20Yubrine Moraa Gachemba: BETULA Adds New Evidence for Catheter-Directed Thrombolysis in PE
-
Sep 5, 2026, 19:18John R. Mehall: The Importance of Anticoagulation Management in ECMO
-
Sep 5, 2026, 19:16Thirunavukkarasu Angappan: Why Hemophilia B Still Needs Both Plasma-Derived and Recombinant Factor IX
-
Sep 5, 2026, 19:15Michelle Leona Cecil: Comprehensive Hemophilia Care Doesn’t Begin and End With One Appointment
-
Sep 5, 2026, 19:13Amparo Santamaria: Stem Cells and Hematology – Unlocking a New Frontier in Ovarian Regeneration
-
Sep 5, 2026, 19:10Strengthening the Public Health System for Blood Disorders – Hemophilia Federation of America
-
Sep 5, 2026, 19:08Deidra D. Harris: Supporting Hemophilia of Georgia and the Bleeding Disorders Community
-
Sep 5, 2026, 19:06Katherine Blackwell: Blessed to Have the Opportunity to Speak at the Hemophilia of Indiana Annual Meeting
-
Sep 5, 2026, 19:04Christy V.: What You Need to Know about GI Bleeding and Hemophilia